We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AspenBio Launches Lateral Flow Division

By Labmedica staff writers
Posted on 18 Mar 2004
The launch of a Lateral Flow Division for the development, manufacturing, and distribution of immunochromatographic rapid tests has been announced by AspenBio, Inc. More...
(Castle Rock, CO, USA).

Immunochromatographic tests are used to determine the presence or absence of minute quantities of target analyte in various types of samples within a few minutes and are particularly useful as clinical diagnostic tools. One example is the home pregnancy test. The tests can save clinicians up to 12 hours of laboratory time by replacing immunoblotting in some cases. AspenBio has developed tests for insulin, luteinizing hormone, growth hormone, alpha fetoprotein (AFP), mouse IgG, and thyroid stimulating hormone.

"Adding this division to AspenBio's capabilities is in response to requests from universities, research facilities, and veterinarians,” said Dr. Mark Colgin, chief scientist. "These initial devices, in addition to others currently being developed, will assist technicians, scientists, and doctors with reduced analytical costs and shortened turnaround times.”




Related Links:
AspenBio

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.